Taiwanese Healthcare Undervalued based on future growth

Results

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

4 companies

Universal Vision Biotechnology

Market Cap: NT$14.4b

Operates a chain of eye care clinics in Taiwan and China.

3218

NT$170.00

-5.8%

-29.3%

Visco Vision

Market Cap: NT$11.9b

Manufactures and sells silicone hydrogel contact lenses in Asia, Europe, and the Americas.

6782

NT$189.00

-9.1%

-19.1%

CHC Healthcare Group

Market Cap: NT$9.1b

Engages in trading of pharmaceutical products and health food in Taiwan, China, and internationally.

4164

NT$48.80

-2.6%

13.4%

Apex Biotechnology

Market Cap: NT$3.1b

Researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide.

1733

NT$30.80

0.3%

4.1%